CVE-2026-24164
Essential information
- Published
- 31/03/2026 17:16
- Modified
- 01/04/2026 14:24
- Author
- —
- Creator
- —
- CVSS
- 8.8 HIGH (v3.1)
- CISA KEV
- No
- CWE
- —
- CVSS vector
-
—
CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:H/I:H/A:H—
CVSS metrics
- Access vector
- —
- Access complexity
- —
- Authentication
- —
- Confidentiality impact
- —
- Integrity impact
- —
- Availability impact
- —
- Exploitability
- —
- Remediation level
- —
- Report confidence
- —
- Temporal score
- —
- Attack vector
- NETWORK
- Attack complexity
- LOW
- Privileges required
- NONE
- User interaction
- REQUIRED
- Scope
- UNCHANGED
- Confidentiality impact
- HIGH
- Integrity impact
- HIGH
- Availability impact
- HIGH
- Exploit code maturity
- —
- Remediation level
- —
- Report confidence
- —
- Temporal score
- —
- Attack vector
- —
- Attack complexity
- —
- Attack requirements
- —
- Privileges required
- —
- User interaction
- —
- Confidentiality (V)
- —
- Confidentiality (S)
- —
- Integrity (V)
- —
- Integrity (S)
- —
- Availability (V)
- —
- Availability (S)
- —
- Exploit maturity
- —
Description
NVIDIA BioNeMo contains a vulnerability where a user could cause a deserialization of untrusted data. A successful exploit of this vulnerability might lead to code execution, denial of service, information disclosure, and data tampering.
NVD status
- Status
- Awaiting Analysis — CVE has been recently published to the CVE List and has been received by the NVD.
- Source
- [email protected]
- NVD
- View on NVD
Affected products (CPE)
| Product | CPE |
|---|---|
| nvidia / bionemo | cpe:2.3:a:nvidia:bionemo:*:*:*:*:*:*:*:* |